Cornea - ARVO

More documents

Recommendations

Info

ARVO 2013 Annual Meeting Abstracts by Scientific Section/Group - Corneapercent of surface area) for the inferior and central corneal regionswere 0.236% (SD:50.04) and 0.182% (SD:37.34), respectively.Visual confirmation showed close qualitative agreement withsoftware results. Processing of all 2660 images requiredapproximately 60 minutes. Computed log SPK number of a randomlyselected subset of 54 images showed a 92% correlation with a clinicalgrader assessment using the Ora staining scale (0-4).Conclusions: The results show that extensive and accurateinformation may be efficiently obtained with the software basedapproach. We note that mean SPK numbers and the stained area arehigher in the inferior then the central corneal region, although therespective geometric areas are the same. The automated selection ofthe relevant region of interest and enumeration of up to severalhundred SPK quickly and efficiently allows for precise and accuratequantification of corneal desiccation.Commercial Relationships: John D. Rodriguez, Ora, Inc. (E);Patrick Johnston, Ora, Inc (E); Keith J. Lane, Ora, Inc. (E);George W. Ousler, Ora, Inc. (E)Program Number: 4342 Poster Board Number: C0080Presentation Time: 8:30 AM - 10:15 AMOcular Surface Disease prevalence in Glaucoma patients in aHigh Referral Ophthalmology Center in Mexico CityNallely Ramos-Betancourt 1 , Jaime D. Martinez 1 , Francisco Beltran 1 ,Jorge Ozorno-Zarate 1 , Cristina G. Isida Llerandi 2 , Jesus Jimenez-Roman 2 , Felix Gil Carrasco 2 , Manuel Ramirez 1 , EverardoHernandez-Quintela 1 . 1 Cornea, Asociacion Para Evitar la Ceguera,Mexico City, Mexico; 2 Glaucoma, Asociación Para Evitar la Cegueraen México, Mexico City, Mexico.Purpose: To determine the ocular surface disease (OSD) prevalencein glaucoma patients and risk factors.Methods: A cross-sectional study was designed. Consecutiverecruitment of patients was made in the Glaucoma department fromoctober to november 2012. Patients older than 18 years old, usingantiglaucomatous topical medication were included. They underwentophthalmological examination which comprised: Ocular SurfaceDisease Index (OSDI) questionnaire, tear film break up time(TFBUT), ocular surface staining with fluorescein, Schirmer I testwith anesthesia, and the presence of Meibomian gland dysfunction.Additionaly, the following risk factors were evaluated: age, sex,number and type of antiglaucomatous topical medications, time ofusage, ocular surgery history.Results: 123 patients were recruited, 87 patients (71.55%) werefemales. The mean age was 67.85 +/- 13.26 years (range, 21-90). TheOSD prevalence was 51.21% by OSDI (15.44% mild, 12.1%moderate and 23.5% severe). 104 patients (84.55%) had abnormalTFBUT (
ARVO 2013 Annual Meeting Abstracts by Scientific Section/Group - Corneapresent and functional in the lacrimal gland, if they exhibit sexspecificdifferences, and if a DHA-rich diet can confer protectiveactions against DE developmentMethods: DE was induced using a model of desiccating stress andscopolamine. Mice were placed on a DHA-rich or DHA-deficient dietfor 4 weeks before DE induction. Schirmer’s test was used to assesstear levels. PMN levels were quantified using myeloperoxidase assay,lipid mediator formation by LC/MS/MS-based lipidomics, and geneexpression via QPCR. Leukocyte populations were assessed by IHCResults: Lacrimal glands highly express inflammatory lipid circuits(COX, 15-LOX), which are regulated by desiccating stress. Femalemice exhibited an amplified inflammatory response compared tomales, evidenced by a marked early infiltration of PMNs, increasedpro-inflammatory PGE2, and decreased pro-resolving LXA4. Micethat received the DHA-rich diet had higher tear production (0.9mm)compared to their DHA-poor diet counterparts (0.3mm), suggestinggreater protection against desiccating stress. DHA-rich micecontained greater levels of DHA and EPA, and lower levels of ω-6PUFA AA. Levels of PGE2 were downregulated 2.4-fold and proresolvinglipid mediators were upregulated in mice on the enrichedDHA dietConclusions: These results provide the first evidence that lipidautacoid circuits are expressed and functional in vivo in lacrimalglands. There is a sex-specific difference in the inflammatoryresponse to desiccating stress. Dietary DHA in females shifts levelsof lipid mediators to resemble males and may confer protectionagainst disease progression by downregulating the immuneregulatory COX/PGE2 pathway, a primary target of corticosteroidsand NSAIDsCommercial Relationships: Kyle M. Hu, None; Samantha B.Wang, None; Erick Lu, None; Patrick J. Salveson, None; YuanGao, None; Karsten Gronert, NoneSupport: EY022208 and Sjogren's Syndrome FoundationProgram Number: 4345 Poster Board Number: C0083Presentation Time: 8:30 AM - 10:15 AMAnalysis of Electrolyte Composition of Precorneal Tear Film inNormal Dogs and Horses and its Comparative Values in Serumand PlasmaGil Ben-Shlomo, LaTisha N. Taylor. Veterinary Clinical Sciences,College of Veterinary Medicine, Iowa State University, Ames, IA.Purpose: Serum and plasma are being used for the treatment ofseveral eye diseases including keratomalacia and Keratoconjunctivitissicca. The goals of this study was to analyze the electrolyte contentfound in equine and canine tears and compare it to the electrolytesfound in serum and plasma obtained by utilizing two differentanticoagulants.Methods: Nine horses (17 eyes) and 9 dogs (18 eyes) were used inthis study. An eye examination including slit lamp biomicroscopy,fundoscopy, and Schirmer tear test (STT) was performed. All eyeswere free of ocular disease. All horses were sedated with 0.5 mg/kgof xylazine (Lloyd Laboratories, Shenandoah, IA) intravenously. Nochemical restraint was needed for the dogs. Tears and blood werecollected from all animals. Blood was collected for serum in tubeswith no anticoagulants; plasma was made by using two differentanticoagulants: Citrate Phosphate Dextrose (CPD) and heparin.Results: Most of the electrolyte values in tears were statisticallydifferent than electrolyte values in serum and plasma in both dogsand horses. In both species, potassium and chloride levels weresignificantly (P
Page 2 and 3:
ARVO 2013 Annual Meeting Abstracts
Page 4 and 5:
Page 6 and 7:
Page 8 and 9:
Page 10:
Page 13 and 14:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225: ARVO 2013 Annual Meeting Abstracts
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
show all

Cornea - ARVO

Create successful ePaper yourself

Delete template?

Save as template?